Showing results (1651-1660 of 2,364) with videos related to

Sort By:
Pageof 237
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|January 30, 2004
Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventionsEugenia Nikolsky, Roxana Mehran, Gary S Mintz, et al.
Journal of the American College of Cardiology|April 20, 2019
Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main DiseaseRodrigo Modolo, Ply Chichareon, Norihiro Kogame, et al.
Circulation|October 1, 2019
Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT TrialSuzanne J Baron, Kaijun Wang, Suzanne V Arnold, et al.
Circulation|March 30, 1999
Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trialG W Stone, B R Brodie, J J Griffin, et al.
European Heart Journal|March 1, 2005
Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarctionPaul Sorajja, Bernard J Gersh, Costantino Costantini, et al.
The American Journal of Cardiology|October 13, 2004
Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarctionDavid E Kandzari, James E Tcheng, Cindy L Grines, et al.
The American Journal of Cardiology|August 14, 2017
Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX)Muthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.
European Heart Journal|August 19, 2005
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-upDebabrata Mukherjee, Eric J Topol, Michel E Bertrand, et al.
The American Journal of Cardiology|July 9, 2010
SPIRIT III JAPAN versus SPIRIT III USA: a comparative intravascular ultrasound analysis of the everolimus-eluting stentTakao Shimohama, Junya Ako, Masao Yamasaki, et al.
Circulation|September 1, 2010
Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trialNing Guo, Akiko Maehara, Gary S Mintz, et al.
Pageof 237